Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Stock Picking - 2003 -- Ignore unavailable to you. Want to Upgrade?

To: RCMac who wrote (49)	1/3/2003 7:53:05 PM
From: scott_jiminez	Read Replies (1) \| Respond to of 383

<<A buying program, let alone an order, for 300,000+ shares would have driven up the price by a wide margin. Hence the unreality of your UNVC position.>> Hmmm. That's a bizarre and highly selective stance since you didn't seem to flick a sanctimonious eyelash when an 'order' was put in to buy almost 14,000 shares of a $1.46 stock siliconinvestor.com (which, according to you, would have an effect on the share price of VPHM that would differ from the UNVC scenario only by degree...but not in the 'unreality' of the position). See my previous post regarding AMGN. (The word 'whit' does exist [e.g. I don't give a whit] but I did indeed misuse it in the context of my post. I stand corrected. Oh, and BTW, the TRUTH of this whole silly spat is that I chose the 8 stocks I wanted to include, did the math and created the portfolio without thinking twice about the ridiculous number shares of UNVC I was 'buying'. The fact is that UNVC was the ONLY carryover from my portfolio of last year (and there was absolutely no debate of its 'biotechworthiness' then nor the huge amount of shares I 'bought'). If the approach to the 300K thing would have been less arrogant and idiotic, my response would have been considerably more receptive.)